Tom Robinson, vice president of global access at JDRF, explains how to navigate the Type 1 Diabetes (T1D) Index and what data can be pulled from it.
The Type 1 Diabetes (T1D) Index, which was launched in September, provides payers with a good foundation for value-based health care, said Tom Robinson, vice president of global access at JDRF.
Transcript
How can someone navigate the T1D Index?
The simplest thing is to just go to T1Dindex.org and look at the world map there, maybe compare a few countries that are of interest, and then dive into the one that you care most about. Then it takes you through the story of that country and how type 1 looks today—the growth story, the loss and the burden, and what can be done to address that burden. From there, if you want to go deeper, you can dive into the Lancet paper, or there's a dashboard tool, or the codebase is available open source. So there's a lot of layers to peel beyond that, but starting point is just that T1Dindex.org website.
What information can patients, providers, and payers gain from the T1D Index?
The index is this incredibly rich simulation of each country, but there are 3 main numbers that we draw out of it. The first is how many people are living with type 1. The second is how many people should be alive with type 1 if they received really good care. The third is how many healthy life-years are lost to the average person who develops type 1.
And then for each of those numbers, we also look at how interventions can improve care and change the numbers and change the story of type 1 in that country. And I think how you engage with that is really different depending on who you are. If you're a person living with type 1, you might dive into, "Oh, wow, each extra test trip could add 4 hours to my life. Maybe I'm going to think about marching into that local pharmacy and making sure they stock the test trips." For a provider, they might look at some of the incidence rates and ask, "Hey, are we catching everyone?" or look at the growth estimates and say, "Are we prepared for this? Do we need to think about evolving our model for this rapid growth in type 1?"
For a payer, government, or insurer, you've got some good foundations, frankly, for value-based health care in this model. You can bring your cost models, the epidemiology we've done, and then drop out things like dollars per life-year or get under the hood about complications modeling and look at lifetime health care costs and so forth. Some of this is readily available on the website, some you need to kind of start using the interactive tools to really get to grips with and get the full value out of, but there's a lot of depth behind that kind of initial public face.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Goal Achievement in T1D Management Boosts Self-Efficacy, Self-Care Among Emerging Adults
May 9th 2024Findings from the FAMS-T1D study demonstrate that structured goal-setting and achievement significantly enhance self-efficacy and self-care in emerging adults who have type 1 diabetes (T1D).
Read More